No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
CNTX Context Therapeutics
- 1.0200
- -0.0700-6.42%
Close Dec 20 16:00 ET
- 1.0600
- +0.0400+3.92%
Post 16:56 ET
76.50MMarket Cap-1.16P/E (TTM)
1.1136High0.9606Low339.73KVolume1.0600Open1.0900Pre Close342.64KTurnover0.87%Turnover RatioLossP/E (Static)75.00MShares2.750052wk High0.91P/B39.73MFloat Cap0.890052wk Low--Dividend TTM38.95MShs Float10.8700Historical High--Div YieldTTM14.04%Amplitude0.4700Historical Low1.0080Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Context Therapeutics Secures Funding for Cancer Therapy Pipeline
Context Therapeutics Enters $75M At-The-Market Offering Agreement, Allocating Proceeds To R&D, Working Capital, And Potential Asset Acquisitions
Express News | Context Therapeutics Inc - Under Sales Agreement, May Offer & Sell up to $75 Million in Common Stock
Express News | Context Therapeutics Inc - Enters Sales Agreement With Leerink Partners
D. Boral Capital Initiates Coverage On Context Therapeutics With Buy Rating, Announces Price Target of $9
Context Therapeutics Analyst Ratings
Heat List
US
Overall
Symbol
Price
% Chg
No Data